Skip to main content
. 2020 Aug 3;10:342. doi: 10.3389/fcimb.2020.00342

Table 1.

Clinical characteristics.

Characteristics AIH (n = 37) HC (n = 78) P-value
Age, years, median (min–max) 50 (25–72) 49.5 (36-65) 0.469
Gender, Female, n (%) 34 (91.89%) 67 (85.9%) 0.358
BMI, kg/m2, median (min–max) 21.89 (18.47–29.34) 22.04 (18.31–29.34) 0.962
HEPATIC FUNCTION, MEDIAN (MIN–MAX)
ALT, U/L 160 (47–553) 16 (7–38) 0.000-
AST, U/L 95 (40–407) 20 (11–33) 0.000
AKP, U/L 70 (40–263) 69 (32–157) 0.296
GGT, U/L 90 (54–321) 17 (7–49) 0.000
TB, umol/L 20 (6–71) 11.305 (3.8–18.12) 0.000
ALB, g/L 36 (29–54) 47.35 (39.6–53.2) 0.000
IMMUNOGLOBULIN, MEDIAN (MIN–MAX)
IgG, g/L 21.3 (9.82–44)
IgM, g/L 1.5 (0.51–4.2)
IgA, g/L 1.8 (0.6–8.63)
AUTOANTIBODY, ±, +%
ANA 33/4; 89.19%
ASMA 5/32; 13.51%
SLA/LP 9/28; 24.32%

Continuous variables were compared using Wilcoxon rank sum test between both groups. Fisher's exact test compared categorical variables. Statistical analyses were performed using SPSS version 20.0 for Windows (SPSS Inc., Chicago, IL).

BMI, body mass index; AIH, autoimmune hepatitis; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AKP, alkaline phosphatase; GGT, gamma-glutamyltransferase; TB, total bilirubin; ALB, albumin.